Endothelial Lipase as a New Diagnostic Marker in Patients with Nonalcoholic Fatty Liver Disease and Metabolic Syndrome
| dc.contributor.author | Bashkirova, Anna | |
| dc.date.accessioned | 2019-11-26T07:52:22Z | |
| dc.date.available | 2019-11-26T07:52:22Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | The concentration of EL is lowest in patients of the control group and increases progressively with steatosis and metabolic syndrome compared with those suffering from hypertension without steatosis and metabolic syndrome. In ad- dition, an increase in EL is associated with the presence of met- abolic disorders, which, in aggregate, makes it possible to at- tribute it to independent markers of the atherosclerotic process and cardiovascular risk. | ru_RU |
| dc.identifier.citation | Bashkirova A. Endothelial Lipase as a New Diagnostic Marker in Patients with Nonalcoholic Fatty Liver Disease and Metabolic Syndrome / A. Bashkirova // International Conference on Fatty Liver (ICFL), Berlin, Germany, June 27–29 2019 : Abstract book. – Berlin, 2019. – P. 24–25. | ru_RU |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/24887 | |
| dc.language.iso | en | ru_RU |
| dc.subject | NAFLD | ru_RU |
| dc.subject | metabolic syndrome | ru_RU |
| dc.subject | endothelial lipase | ru_RU |
| dc.title | Endothelial Lipase as a New Diagnostic Marker in Patients with Nonalcoholic Fatty Liver Disease and Metabolic Syndrome | ru_RU |
| dc.type | Article | ru_RU |